BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 2020
View Archived Issues
Depression's structural problem
Read More
Modeling the post-infarct heart
Read More
Narrower interferon activity could benefit immune therapy
Read More
Fetal pharmacotherapy in the developing inner ear may rescue congenital deafness
Read More
Researchers find mutated ATP10B to increase risk of Parkinson's disease
Read More
SOM Biotech identifies three drug candidates for COVID-19
Read More
First patient dosed in global study of low-dose selinexor in severe COVID-19
Read More
Encouraging data reported for Ruconest in patients with COVID-19
Read More
Novel IL-27-based targeting gene therapy shows promise in prostate cancer models
Read More
Novel ferret model of infection and rapid transmission of SARS-CoV-2
Read More
Neobiotek divulges new DPP-IV inhibitors
Read More
Genentech and Roche present MAP4K1 inhibitors
Read More
Kubota Pharmaceutical Holdings synthesizes AOC3 inhibitors
Read More
LG Chem discloses ketohexokinase inhibitors
Read More
Japanese researchers synthesize compounds for Ebola virus infection
Read More
Harbour BioMed initiates phase Ib/IIa study of batoclimab in NMOSD
Read More
Phase II trial of Tesomet in hypothalamic obesity shows improvements on key efficacy endpoints
Read More
Enrollment complete in INSIGHT-004 study of eftilagimod alpha with avelumab in advanced solid tumors
Read More
Arcutis initiates phase I/IIb study of ARQ-252 for chronic hand eczema
Read More
FDA approves Imbruvica with rituximab for previously untreated CLL or SLL
Read More
Tempest enrolling in phase Ia/Ib study of TPST-1495 for advanced solid tumors
Read More
New model shows role of Pin1 in neuronal excitability and cognitive flexibility
Read More
FDA accepts IND for study of ATYR-1923 for COVID-19 patients with severe respiratory complications
Read More
IRE1-alpha deletion protects from type 1 diabetes through beta cell dedifferentiation
Read More